CA2863959C - Kiosque medical et son procede d'utilisation - Google Patents
Kiosque medical et son procede d'utilisation Download PDFInfo
- Publication number
- CA2863959C CA2863959C CA2863959A CA2863959A CA2863959C CA 2863959 C CA2863959 C CA 2863959C CA 2863959 A CA2863959 A CA 2863959A CA 2863959 A CA2863959 A CA 2863959A CA 2863959 C CA2863959 C CA 2863959C
- Authority
- CA
- Canada
- Prior art keywords
- patient
- medical
- information
- kiosk
- allowing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 233
- 239000003814 drug Substances 0.000 claims description 190
- 229940079593 drug Drugs 0.000 claims description 158
- 230000008569 process Effects 0.000 claims description 69
- 238000011012 sanitization Methods 0.000 claims description 68
- 230000036772 blood pressure Effects 0.000 claims description 62
- 238000002483 medication Methods 0.000 claims description 57
- 208000024891 symptom Diseases 0.000 claims description 50
- 239000000463 material Substances 0.000 claims description 47
- 238000013479 data entry Methods 0.000 claims description 39
- 230000006870 function Effects 0.000 claims description 38
- 206010020751 Hypersensitivity Diseases 0.000 claims description 32
- 230000007815 allergy Effects 0.000 claims description 31
- 239000008280 blood Substances 0.000 claims description 20
- 210000004369 blood Anatomy 0.000 claims description 20
- 239000003595 mist Substances 0.000 claims description 19
- 238000004140 cleaning Methods 0.000 claims description 18
- 230000008859 change Effects 0.000 claims description 16
- 230000033001 locomotion Effects 0.000 claims description 12
- 230000009471 action Effects 0.000 claims description 10
- 239000011521 glass Substances 0.000 claims description 8
- 238000012795 verification Methods 0.000 claims description 8
- 230000003993 interaction Effects 0.000 claims description 7
- 230000036961 partial effect Effects 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 6
- 239000000955 prescription drug Substances 0.000 claims description 6
- 210000001525 retina Anatomy 0.000 claims description 6
- 238000012552 review Methods 0.000 claims description 6
- 238000003745 diagnosis Methods 0.000 claims description 5
- 239000003168 generic drug Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000013475 authorization Methods 0.000 claims description 3
- 208000036647 Medication errors Diseases 0.000 claims description 2
- 230000000670 limiting effect Effects 0.000 description 196
- 230000036541 health Effects 0.000 description 72
- 238000013461 design Methods 0.000 description 18
- 238000005516 engineering process Methods 0.000 description 13
- 210000001508 eye Anatomy 0.000 description 13
- 239000002184 metal Substances 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 11
- 244000005700 microbiome Species 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 230000001954 sterilising effect Effects 0.000 description 10
- 238000004659 sterilization and disinfection Methods 0.000 description 10
- 208000026935 allergic disease Diseases 0.000 description 9
- 239000004033 plastic Substances 0.000 description 9
- 229920003023 plastic Polymers 0.000 description 9
- 238000007726 management method Methods 0.000 description 8
- 239000002023 wood Substances 0.000 description 8
- 241000870659 Crassula perfoliata var. minor Species 0.000 description 7
- 208000010201 Exanthema Diseases 0.000 description 7
- 244000052616 bacterial pathogen Species 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 201000005884 exanthem Diseases 0.000 description 7
- 206010037844 rash Diseases 0.000 description 7
- 230000008439 repair process Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 238000009223 counseling Methods 0.000 description 6
- 238000000968 medical method and process Methods 0.000 description 6
- 239000000123 paper Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 201000009890 sinusitis Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000005141 Otitis Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 238000012790 confirmation Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000000249 desinfective effect Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 208000019258 ear infection Diseases 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 206010022000 influenza Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 239000012780 transparent material Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- 208000031973 Conjunctivitis infective Diseases 0.000 description 3
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 3
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 240000001624 Espostoa lanata Species 0.000 description 3
- 235000009161 Espostoa lanata Nutrition 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 229960004544 cortisone Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 230000002207 retinal effect Effects 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- 208000007848 Alcoholism Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 208000003174 Brain Neoplasms Diseases 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000030814 Eating disease Diseases 0.000 description 2
- 208000019454 Feeding and Eating disease Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 208000032041 Hearing impaired Diseases 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 206010028735 Nasal congestion Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241001674048 Phthiraptera Species 0.000 description 2
- 206010051482 Prostatomegaly Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000159243 Toxicodendron radicans Species 0.000 description 2
- 241000893966 Trichophyton verrucosum Species 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 229960003022 amoxicillin Drugs 0.000 description 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000014632 disordered eating Nutrition 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000000613 ear canal Anatomy 0.000 description 2
- 210000000959 ear middle Anatomy 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000004905 finger nail Anatomy 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 230000004199 lung function Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 208000022821 personality disease Diseases 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 231100000046 skin rash Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 208000000103 Anorexia Nervosa Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- 208000036640 Asperger disease Diseases 0.000 description 1
- 201000006062 Asperger syndrome Diseases 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 206010006811 Bursitis Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000015943 Coeliac disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000000907 Condylomata Acuminata Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000025967 Dissociative Identity disease Diseases 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 108010074604 Epoetin Alfa Proteins 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- 206010052140 Eye pruritus Diseases 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 208000011688 Generalised anxiety disease Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- 208000004898 Herpes Labialis Diseases 0.000 description 1
- 208000034991 Hiatal Hernia Diseases 0.000 description 1
- 206010020028 Hiatus hernia Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 208000030990 Impulse-control disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 208000003456 Juvenile Arthritis Diseases 0.000 description 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- 108010007859 Lisinopril Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000027120 Narcissistic personality disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 1
- 206010057342 Onychophagia Diseases 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010033664 Panic attack Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241000517307 Pediculus humanus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 208000004362 Penile Induration Diseases 0.000 description 1
- 208000012202 Pervasive developmental disease Diseases 0.000 description 1
- 208000020758 Peyronie disease Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000028665 Reactive Attachment disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010052251 Respiratory tract congestion Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000005793 Restless legs syndrome Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 206010041738 Sports injury Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000034972 Sudden Infant Death Diseases 0.000 description 1
- 206010042440 Sudden infant death syndrome Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043183 Teething Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 206010057644 Testis cancer Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010070488 Upper-airway cough syndrome Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 206010049644 Williams syndrome Diseases 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- YYAZJTUGSQOFHG-IAVNQIGZSA-N [(6s,8s,10s,11s,13s,14s,16r,17r)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate;2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]eth Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)C1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O YYAZJTUGSQOFHG-IAVNQIGZSA-N 0.000 description 1
- 229940056213 abilify Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940062328 actos Drugs 0.000 description 1
- 229940090167 advair Drugs 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000008445 altitude sickness Diseases 0.000 description 1
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 description 1
- 229960004005 amlodipine besylate Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000025009 anogenital human papillomavirus infection Diseases 0.000 description 1
- 201000004201 anogenital venereal wart Diseases 0.000 description 1
- 208000024823 antisocial personality disease Diseases 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- FQCKMBLVYCEXJB-MNSAWQCASA-L atorvastatin calcium Chemical compound [Ca+2].C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1.C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 FQCKMBLVYCEXJB-MNSAWQCASA-L 0.000 description 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
- 208000029560 autism spectrum disease Diseases 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 208000027499 body ache Diseases 0.000 description 1
- 208000022266 body dysmorphic disease Diseases 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000019069 chronic childhood arthritis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940066901 crestor Drugs 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000007784 diverticulitis Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 206010013932 dyslexia Diseases 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229940089118 epogen Drugs 0.000 description 1
- KWORUUGOSLYAGD-YPPDDXJESA-N esomeprazole magnesium Chemical compound [Mg+2].C([S@](=O)C=1[N-]C2=CC=C(C=C2N=1)OC)C1=NC=C(C)C(OC)=C1C.C([S@](=O)C=1[N-]C2=CC=C(C=C2N=1)OC)C1=NC=C(C)C(OC)=C1C KWORUUGOSLYAGD-YPPDDXJESA-N 0.000 description 1
- 239000003000 extruded plastic Substances 0.000 description 1
- 208000011323 eye infectious disease Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000011094 fiberboard Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000029364 generalized anxiety disease Diseases 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 201000000079 gynecomastia Diseases 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 description 1
- 229960000240 hydrocodone Drugs 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 201000006747 infectious mononucleosis Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229960003918 levothyroxine sodium Drugs 0.000 description 1
- 208000028454 lice infestation Diseases 0.000 description 1
- 229940002661 lipitor Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960002394 lisinopril Drugs 0.000 description 1
- RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000001809 melena Anatomy 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229960005127 montelukast Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000027881 multiple personality disease Diseases 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229940112641 nexium Drugs 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 238000009206 nuclear medicine Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 208000030613 peripheral artery disease Diseases 0.000 description 1
- 208000019899 phobic disease Diseases 0.000 description 1
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 1
- 229940020573 plavix Drugs 0.000 description 1
- 208000028173 post-traumatic stress disease Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000010344 pupil dilation Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- ZTHJULTYCAQOIJ-WXXKFALUSA-N quetiapine fumarate Chemical compound [H+].[H+].[O-]C(=O)\C=C\C([O-])=O.C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12.C1CN(CCOCCO)CCN1C1=NC2=CC=CC=C2SC2=CC=CC=C12 ZTHJULTYCAQOIJ-WXXKFALUSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- LALFOYNTGMUKGG-BGRFNVSISA-L rosuvastatin calcium Chemical compound [Ca+2].CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O.CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O LALFOYNTGMUKGG-BGRFNVSISA-L 0.000 description 1
- 210000000513 rotator cuff Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940035004 seroquel Drugs 0.000 description 1
- 230000035911 sexual health Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000036346 tooth eruption Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- -1 urine samples Substances 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7465—Arrangements for interactive communication between patient and care services, e.g. by using a telephone network
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation; Time management
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Vascular Medicine (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Nursing (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
L'invention concerne un kiosque médical conçu pour fournir des services de télémédecine, des services d'inscription et/ou des services de prescription pour un utilisateur. Le kiosque médical peut comprendre un système de vidéoconférence pour utilisateur qui est conçu pour permettre à l'utilisateur d'avoir une téléconférence en temps réel ou en temps quasi-réel avec un dispensateur de soins médicaux situé à distance du kiosque médical.
Applications Claiming Priority (31)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261595879P | 2012-02-07 | 2012-02-07 | |
US201261595919P | 2012-02-07 | 2012-02-07 | |
US201261595886P | 2012-02-07 | 2012-02-07 | |
US201261595913P | 2012-02-07 | 2012-02-07 | |
US201261595871P | 2012-02-07 | 2012-02-07 | |
US201261595876P | 2012-02-07 | 2012-02-07 | |
US201261595863P | 2012-02-07 | 2012-02-07 | |
US61/595,876 | 2012-02-07 | ||
US61/595,913 | 2012-02-07 | ||
US61/595,879 | 2012-02-07 | ||
US61/595,863 | 2012-02-07 | ||
US61/595,871 | 2012-02-07 | ||
US61/595,886 | 2012-02-07 | ||
US61/595,919 | 2012-02-07 | ||
US201261596302P | 2012-02-08 | 2012-02-08 | |
US201261596288P | 2012-02-08 | 2012-02-08 | |
US201261596298P | 2012-02-08 | 2012-02-08 | |
US201261596294P | 2012-02-08 | 2012-02-08 | |
US201261596290P | 2012-02-08 | 2012-02-08 | |
US201261596306P | 2012-02-08 | 2012-02-08 | |
US201261596304P | 2012-02-08 | 2012-02-08 | |
US61/596,294 | 2012-02-08 | ||
US61/596,304 | 2012-02-08 | ||
US61/596,288 | 2012-02-08 | ||
US61/596,290 | 2012-02-08 | ||
US61/596,306 | 2012-02-08 | ||
US61/596,302 | 2012-02-08 | ||
US61/596,298 | 2012-02-08 | ||
US201361755662P | 2013-01-23 | 2013-01-23 | |
US61/755,662 | 2013-01-23 | ||
PCT/US2013/024911 WO2013119646A1 (fr) | 2012-02-07 | 2013-02-06 | Kiosque médical et son procédé d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2863959A1 CA2863959A1 (fr) | 2013-08-15 |
CA2863959C true CA2863959C (fr) | 2021-05-04 |
Family
ID=48947954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2863959A Active CA2863959C (fr) | 2012-02-07 | 2013-02-06 | Kiosque medical et son procede d'utilisation |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2811897A4 (fr) |
CN (1) | CN104244812B (fr) |
CA (1) | CA2863959C (fr) |
WO (1) | WO2013119646A1 (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9959385B2 (en) | 2013-02-15 | 2018-05-01 | Davincian Healthcare, Inc. | Messaging within a multi-access health care provider portal |
US11354623B2 (en) | 2013-02-15 | 2022-06-07 | Dav Acquisition Corp. | Remotely diagnosing conditions and providing prescriptions using a multi-access health care provider portal |
BR102014001606A2 (pt) * | 2014-01-23 | 2018-11-21 | Ismael Nobre | processo integrado e automatizado de obtenção, gerenciamento e disponibilização de informações multidimensionais para pesquisas de percepção e opinião pública e equipamento para sua realização |
CN105286849A (zh) * | 2015-04-24 | 2016-02-03 | 于洋 | 一种具有语音反馈功能的心电图采集装置 |
CN104897885A (zh) * | 2015-04-25 | 2015-09-09 | 王超 | 全方面医疗检验装置 |
US11068941B2 (en) | 2015-08-18 | 2021-07-20 | Cvs Pharmacy, Inc. | Techniques for in-store prescription notifications |
CN105534508A (zh) * | 2015-12-17 | 2016-05-04 | 季婷婷 | 一种智能护理机 |
CN107483869A (zh) * | 2016-06-20 | 2017-12-15 | 上海飞机客户服务有限公司 | 服务请求及视频处理方法、装置及设备 |
CN107564586A (zh) * | 2016-06-30 | 2018-01-09 | 上海人智信息科技有限公司 | 一种远程移动医疗工作站 |
CN106326662B (zh) * | 2016-08-30 | 2019-04-09 | 贵阳朗玛信息技术股份有限公司 | 一种视频就诊流程调整方法及装置 |
CN106236021A (zh) * | 2016-08-31 | 2016-12-21 | 牟伟 | 一种用于检测身体指标并能直接打印的装置 |
EP3312762B1 (fr) * | 2016-10-18 | 2023-03-01 | Axis AB | Procédé et système permettant de suivre un objet dans une zone définie |
CN106485095A (zh) * | 2016-12-26 | 2017-03-08 | 春秋航空股份有限公司 | 一种远程航医系统 |
CN108511054A (zh) * | 2017-02-23 | 2018-09-07 | 仁智(苏州)医学研究有限公司 | 一种辅助诊疗的方法和诊疗辅助系统 |
CN108846975B (zh) * | 2018-06-15 | 2020-10-27 | 重庆优豆商贸有限公司 | 共享型智能商品交易机器人 |
CN108814561A (zh) * | 2018-07-11 | 2018-11-16 | 山东博科保育科技股份有限公司 | 经皮黄疸仪智能控制方法、装置及系统 |
CN108694782B (zh) * | 2018-07-23 | 2020-12-25 | 北京瑞齐宁生物技术有限公司 | 健康共享小屋的控制方法及健康共享小屋系统 |
CN108877345A (zh) * | 2018-07-27 | 2018-11-23 | 广西第二课堂教育咨询有限公司 | 一种面向孤独症谱系障碍儿童的智能教学系统 |
CN108985970A (zh) * | 2018-08-01 | 2018-12-11 | 深圳春沐源控股有限公司 | 信息显示方法、装置、系统及终端 |
CN109044274A (zh) * | 2018-08-02 | 2018-12-21 | 厦门娜其尔日化股份有限公司 | 一种皮肤测试吧及皮肤测试方法 |
CN109447232A (zh) * | 2018-10-30 | 2019-03-08 | 北京猎户星空科技有限公司 | 机器人主动问询方法、装置、电子设备及存储介质 |
CN109567755A (zh) * | 2018-12-05 | 2019-04-05 | 成都云卫康医疗科技有限公司 | 一种睡眠呼吸监测设备的管理系统及商业模式 |
CN109779329B (zh) * | 2019-04-02 | 2024-01-30 | 武汉柏马文化科技有限公司 | 商品销售亭 |
JP7147706B2 (ja) * | 2019-07-22 | 2022-10-05 | トヨタ自動車株式会社 | 乗物、情報処理システム、プログラム、および情報処理方法 |
CN112289100A (zh) * | 2019-07-25 | 2021-01-29 | 上海力本规划建筑设计有限公司 | 一种智慧教室系统 |
WO2021055867A1 (fr) * | 2019-09-19 | 2021-03-25 | The Kit Company, Inc. | Systèmes, dispositifs et procédés de collecte à distance de données biométriques et d'échantillon de prélèvement avec vérification d'identité de collecteur |
KR102419333B1 (ko) * | 2019-10-08 | 2022-07-11 | 신봉근 | 헬스 케어 시스템 및 이의 동작 방법 |
CN110808107A (zh) * | 2019-10-24 | 2020-02-18 | 山东勤成信息科技有限公司 | 一种医疗物联网健康服务平台及系统 |
KR102389837B1 (ko) * | 2019-11-15 | 2022-04-21 | 조선대학교산학협력단 | 스트레스 측정 장치 |
WO2021092964A1 (fr) * | 2019-11-16 | 2021-05-20 | 柏兆(吉安)电子有限责任公司 | Système de consultation intelligente de glucose sanguin pour la communauté âgée basé sur médecin électronique |
CN111462859A (zh) * | 2020-03-19 | 2020-07-28 | 成都尚医信息科技有限公司 | 一种基于标签管理的运动康复课程系统 |
CN111652400A (zh) * | 2020-06-08 | 2020-09-11 | 四川记忆码科技有限公司 | 一种医疗门诊亭的在线预约方法及装置 |
CN112160622A (zh) * | 2020-09-23 | 2021-01-01 | 广州联合医生集团有限公司 | 基于vr全景技术的在线诊疗设备 |
DE102020005805A1 (de) | 2020-09-23 | 2022-03-24 | Till Keesmann | Mobiles Mess-, Speicher- und Kommunikationsgerät |
WO2022071876A1 (fr) * | 2020-10-01 | 2022-04-07 | Medlyves Pte Ltd | Kiosque pour services de télémédecine |
CN112582038B (zh) * | 2020-12-08 | 2023-04-25 | 嘉兴易迪希计算机技术有限公司 | 一种个例安全性报告信息整合优化方法 |
CN113035374B (zh) * | 2021-03-16 | 2024-03-12 | 深圳市南山区慢性病防治院 | 一种结核病综合管理系统及管理方法 |
CN113289233B (zh) * | 2021-05-11 | 2022-07-29 | 晋城市人民医院 | 一种远程医疗用一体化终端装置 |
CN113303833B (zh) * | 2021-05-20 | 2022-02-01 | 江苏经纬技术创新咨询有限公司 | 一种智能专家助疗康复设备及组合设备 |
CN113596510A (zh) * | 2021-07-27 | 2021-11-02 | 上海飞机客户服务有限公司 | 服务请求及视频处理方法、装置及设备 |
TWI806124B (zh) * | 2021-08-10 | 2023-06-21 | 宏碁股份有限公司 | 管理病患的看診進度的儀表板系統和方法 |
CN113539039B (zh) * | 2021-09-01 | 2023-01-31 | 山东柏新医疗制品有限公司 | 一种男用扩张型导尿管施药操作训练装置及方法 |
CN113729688A (zh) * | 2021-09-27 | 2021-12-03 | 江苏凤凰智慧教育研究院有限公司 | 肺活量检测平台和方式 |
CN116403604B (zh) * | 2023-06-07 | 2023-11-03 | 北京奇趣万物科技有限公司 | 一种儿童阅读能力评测方法和系统 |
CN116784804A (zh) * | 2023-07-19 | 2023-09-22 | 湖南云医链生物科技有限公司 | 一种未病分析评估系统 |
CN117875299B (zh) * | 2024-03-13 | 2024-05-24 | 南京智握信息技术有限公司 | 一种电子档案集成处理方法及系统 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6205716B1 (en) * | 1995-12-04 | 2001-03-27 | Diane P. Peltz | Modular video conference enclosure |
EP1217942A1 (fr) * | 1999-09-24 | 2002-07-03 | Healthetech, Inc. | Dispositif de surveillance physiologique et unite connexe de calcul, d'affichage et de communication |
US6775567B2 (en) * | 2000-02-25 | 2004-08-10 | Xenogen Corporation | Imaging apparatus |
US20060111620A1 (en) * | 2004-11-23 | 2006-05-25 | Squilla John R | Providing medical services at a kiosk |
US20070265869A1 (en) * | 2006-04-05 | 2007-11-15 | Ryckman Lawrence G | Method and apparatus for physician to interview and dispense directly prescription to patient that is at location remote from physician |
US8595025B2 (en) * | 2007-09-25 | 2013-11-26 | Intel-Ge Care Innovations Llc | Method for routing user service requests from a telemedicine station |
US20090167838A1 (en) * | 2007-12-31 | 2009-07-02 | Poisner David I | Method and apparatus for cleaning a telemedicine station |
US20090240116A1 (en) * | 2008-03-21 | 2009-09-24 | Computerized Screening, Inc. | Triage based managed health kiosk system |
AU2010286375A1 (en) * | 2009-08-31 | 2012-04-26 | Electronic Compliance Solutions, Inc. | Medical compliance kiosk |
WO2011066309A2 (fr) * | 2009-11-25 | 2011-06-03 | Merge Healthcare Incorporated | Systèmes et procédés pour imagerie diagnostique à distance |
-
2013
- 2013-02-06 WO PCT/US2013/024911 patent/WO2013119646A1/fr active Application Filing
- 2013-02-06 EP EP13746087.9A patent/EP2811897A4/fr not_active Withdrawn
- 2013-02-06 CA CA2863959A patent/CA2863959C/fr active Active
- 2013-02-06 CN CN201380018091.5A patent/CN104244812B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2811897A4 (fr) | 2016-10-26 |
EP2811897A1 (fr) | 2014-12-17 |
CA2863959A1 (fr) | 2013-08-15 |
WO2013119646A1 (fr) | 2013-08-15 |
CN104244812B (zh) | 2018-05-11 |
CN104244812A (zh) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10074148B2 (en) | Medical kiosk and method of use | |
CA2863959C (fr) | Kiosque medical et son procede d'utilisation | |
US20180158555A1 (en) | Medical kiosk and method of use | |
US8996392B2 (en) | Medical kiosk and method of use | |
US20170032092A1 (en) | Real Time Multispecialty Telehealth Interactive Patient Wellness Portal (IPWP) | |
CA2881000C (fr) | Kiosque veterinaire avec dispositifs medicaux veterinaires integres | |
CA2826071C (fr) | Kiosque medical et procede d'utilisation | |
WO2017172933A1 (fr) | Kiosque médical et procédé d'utilisation | |
US8620682B2 (en) | Smart clinical care room | |
US20210319895A1 (en) | Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network | |
US8655680B2 (en) | Minimizing disruption during medication administration | |
US20150248536A1 (en) | Modular telemedicine enabled clinic | |
US20130127620A1 (en) | Management of patient fall risk | |
Doherty et al. | Envisioning a better US health care system for all: a call to action by the American College of Physicians | |
Taylor et al. | Telemedicine for general pediatrics | |
US20230223142A1 (en) | Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network | |
CN104878958B (zh) | 医疗亭 | |
Greiwe | Using telemedicine in a private allergy practice | |
Bielaszka-DuVernay | Improving the coordination of care for Medicaid beneficiaries in Pennsylvania | |
Krieger | Home visits for asthma: we cannot afford to wait any longer | |
WO2023112483A1 (fr) | Dispositif de traitement d'informations | |
Elusive | Time’s Up Healthcare Sets a Wake-Up Call |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20180206 |